Gempharmatech Co. Ltd. A Cash Flow Quality Index
Gempharmatech Co. Ltd. A cash flow quality index. Gempharmatech Co. Ltd. A (688046) has a Cash Flow Quality Index of 0.78x as of December 2024. Operating cash flow of CN¥90.31 Million is below net income of CN¥115.79 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Gempharmatech Co. Ltd. A cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Gempharmatech Co. Ltd. A (2019–2024)
Cash flow quality index of Gempharmatech Co. Ltd. A from 2019 to 2024. Historical Cash Flow Quality Index for Gempharmatech Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 688046 net asset quality index to measure how much of total assets are equity-financed.
Gempharmatech Co. Ltd. A Cash Flow Quality Index by Year (2019–2024)
Gempharmatech Co. Ltd. A cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Gempharmatech Co. Ltd. A. For the full cash flow conversion analysis, see cash flow conversion of Gempharmatech Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.78x | CN¥90.31 Million | CN¥115.79 Million | ▲ +6.4% |
| 2023 | 0.73x | CN¥116.57 Million | CN¥158.95 Million | ▲ +13.2% |
| 2022 | 0.65x | CN¥105.98 Million | CN¥163.56 Million | ▼ -28.6% |
| 2021 | 0.91x | CN¥113.31 Million | CN¥124.93 Million | ▼ -50.3% |
| 2020 | 1.83x | CN¥129.79 Million | CN¥71.11 Million | ▼ -2.6% |
| 2019 | 1.87x | CN¥65.12 Million | CN¥34.74 Million | — |